title: The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam.
abstract: OBJECTIVE
  To examine long-term outcome of late-life anxiety disorders and utilization of mental health care services.
  
  
  METHODS
  A cohort of subjects (aged > or = 55 years) with an anxiety disorder (n = 112) was identified in the Longitudinal Aging Study Amsterdam (n = 3107). At 6 year follow-up, the rate of persistence and prognostic factors for persistence of anxiety were established.
  
  
  RESULTS
  Six years after baseline 23% of our sample met the criteria for an anxiety disorder. Another 47% suffered from subclinical anxiety symptoms. Persistence of anxiety was associated with a high score on neuroticism at baseline. Use of benzodiazepines was high (43%), while use of mental health care facilities (14%) and anti-depressants (7%) remained low in those with persistent anxiety.
  
  
  CONCLUSIONS
  Results indicate that those high in neuroticism are at greater risk for persistence of anxiety. Efforts to enhance appropriate referral of anxious older adults do not seem to have had the desired effect.
authors.affiliation: Department of Psychiatry and Institute for Research in Extramural Medicine, Vrije Universiteit Medical Centre/GGZ, Buitenamstel, Amsterdam, The Netherlands. josiens@ggzba.nl
authors.forename: J
authors.initials: J
authors.lastname: Schuurmans
authors.forename: H C
authors.initials: HC
authors.lastname: Comijs
authors.forename: A T F
authors.initials: AT
authors.lastname: Beekman
authors.forename: E
authors.initials: E
authors.lastname: de Beurs
authors.forename: D J H
authors.initials: DJ
authors.lastname: Deeg
authors.forename: P M G
authors.initials: PM
authors.lastname: Emmelkamp
authors.forename: R
authors.initials: R
authors.lastname: van Dyck
mesh_terms: D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000453:epidemiology*; D001569:Benzodiazepines / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D009497:Neurotic Disorders / Q000453:epidemiology; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D001569:Benzodiazepines